GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Subscribe to ...
Omada Health reported revenue of $78 million in the first quarter, up 42% year over year as the company continues to expand its commercial reach and is seeing traction from its big investments in ...
Vincentage Pharma’s oral GLP-1 agonist has been tied to a mean weight loss of 12.4% over a year, setting up the biotech to pursue Eli Lilly’s orforglipron to Chinese regulators. Chengdu-based ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. There have been many headlines in the last week about $50 weight-loss drugs for Medicare ...
Chanel Robinson achieved exactly what the gold rush of blockbuster weight-loss drugs promised: She lost nearly 100 pounds, lowered her cholesterol to normal levels and reined in her polycystic ovary ...
Share on Pinterest The FDA puts forward a move to exclude GLP-1 drugs from the bulk compounding list. Image credit: VICTOR TORRES/Stocksy On April 30, 2026, the U.S. FDA announced it is considering ...
Some patients taking GLP-1 drugs to lose weight or manage Type 2 diabetes are discovering an emerging potential side effect from the blockbuster class of medications: the loss of pleasure or an ...
Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it shifts its business from selling compounded weight loss drugs to branded GLP-1 medications. During ...
Stevee Williams, a restaurant manager in Houston, was preparing for her sister’s wedding when anxieties bubbled up about how she would look in her bridesmaid dress. She was diagnosed with anorexia ...
The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...
A berth in the NBA Finals is on the line as the Spurs take on the Thunder in Game 7 of the Western Conference finals. The defending champs may have fallen short in 2025-26, but the team is filled with ...
For millions of people who have struggled with weight loss, a new experimental drug from Eli Lilly may present the most promising option yet. Today, the pharmaceutical company announced the results ...